The Fort Worth Press - Inspire Veterinary Partners Announces Closing of up to $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

USD -
AED 3.672498
AFN 64.506028
ALL 81.598713
AMD 359.67278
ANG 1.789785
AOA 917.99973
ARS 1538.255899
AUD 1.421171
AWG 1.8025
AZN 1.6682
BAM 1.758181
BBD 2.017808
BDT 124.280834
BGN 1.747831
BHD 0.378105
BIF 3005.600554
BMD 1
BND 1.283543
BOB 11.917476
BRL 5.351899
BSD 1.001892
BTN 95.226537
BWP 13.859348
BYN 2.947424
BYR 19600
BZD 2.014932
CAD 1.40625
CDF 2315.000148
CHF 0.829655
CLF 0.024972
CLP 986.040215
CNY 6.66835
CNH 6.665855
COP 3151.37
CRC 455.595609
CUC 1
CUP 24.044517
CVE 99.123517
CZK 21.86705
DJF 178.40785
DKK 6.718515
DOP 61.444278
DZD 135.338984
EGP 56.0216
ERN 15
ETB 162.972609
EUR 0.89881
FJD 2.243205
FKP 0.75114
GBP 0.751645
GEL 2.570502
GGP 0.75114
GHS 11.676555
GIP 0.75114
GMD 74.000053
GNF 8866.375106
GTQ 7.656419
GYD 209.942467
HKD 7.84465
HNL 26.89794
HRK 6.76901
HTG 131.239943
HUF 329.781502
IDR 18171
ILS 3.02401
IMP 0.75114
INR 95.05725
IQD 1518.788206
IRR 1857000.000028
ISK 122.590193
JEP 0.75114
JMD 159.404525
JOD 0.709026
JPY 157.901503
KES 129.859867
KGS 87.449202
KHR 4090.273689
KMF 440.999906
KPW 899.999961
KRW 1337.469932
KWD 0.31121
KYD 0.834862
KZT 457.910823
LAK 22548.645041
LBP 89716.422674
LKR 333.065143
LRD 170.315667
LSL 16.709083
LTL 2.95274
LVL 0.60489
LYD 6.436563
MAD 9.868303
MDL 18.093068
MGA 4560.450921
MKD 55.35329
MMK 2099.630718
MNT 3601.077836
MOP 8.095253
MRU 40.249373
MUR 47.350154
MVR 15.450298
MWK 1737.250425
MXN 18.68369
MYR 4.083702
MZN 63.910469
NAD 16.709008
NGN 1340.66042
NIO 36.866069
NOK 9.327971
NPR 152.363829
NZD 1.78175
OMR 0.384489
PAB 1.001888
PEN 3.451546
PGK 4.491231
PHP 63.985498
PKR 277.234306
PLN 3.95535
PYG 5828.864747
QAR 3.652104
RON 4.809104
RSD 105.625014
RUB 80.489867
RWF 1482.753351
SAR 3.750764
SBD 8.064647
SCR 13.975707
SDG 601.502436
SEK 9.95023
SGD 1.28161
SHP 0.749344
SLE 22.875022
SLL 20969.504398
SOS 572.550994
SRD 37.6505
STD 20697.981008
STN 22.02465
SVC 8.766631
SYP 13001.999685
SZL 16.701501
THB 33.830216
TJS 9.217057
TMT 3.5
TND 3.000244
TOP 2.40776
TRY 49.837898
TTD 6.800611
TWD 32.419803
TZS 2645.000144
UAH 45.735578
UGX 4393.203883
UYU 40.165228
UZS 11956.976101
VES 886.72915
VND 25837.5
VUV 118.98361
WST 2.767767
XAF 589.580956
XAG 0.018483
XAU 0.000247083183
XCD 2.70255
XCG 1.805556
XDR 0.707052
XOF 589.580956
XPF 107.209637
YER 236.150068
ZAR 16.660535
ZMK 9001.199903
ZMW 20.204154
ZWL 321.999592
SSP 5745.470209
MXV 2.10737
  • RIO

    -0.3300

    97.04

    -0.34%

  • CMSC

    -0.0400

    20.67

    -0.19%

  • RELX

    0.0000

    33.41

    0%

  • RBGPF

    0.0000

    67.95

    0%

  • BCE

    -0.0700

    21.99

    -0.32%

  • BCC

    -0.0300

    75.66

    -0.04%

  • GSK

    0.8600

    51.08

    +1.68%

  • JRI

    -0.0300

    11.52

    -0.26%

  • NGG

    -0.1200

    76.68

    -0.16%

  • CMSD

    0.0900

    20.54

    +0.44%

  • BTI

    -0.0800

    55.75

    -0.14%

  • AZN

    2.0200

    168.1

    +1.2%

  • BP

    -1.4200

    43.16

    -3.29%

  • RYCEF

    0.4600

    19.7

    +2.34%

  • VOD

    0.0700

    17.02

    +0.41%

Inspire Veterinary Partners Announces Closing of up to $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Inspire Veterinary Partners Announces Closing of up to $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Inspire Veterinary Partners Announces Closing of up to $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

VIRGINIA BEACH, VA / ACCESS Newswire / March 26, 2025 / Inspire Veterinary Partners, Inc. (NASDAQ:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S., today announced it has closed a securities purchase agreement with an investor to purchase 1,092,896 shares of its common stock (or pre-funded warrants in lieu thereof), Series A warrants to purchase 1,092,896 shares of common stock and Series B warrants to purchase 1,092,896 shares of common stock, pursuant to a registered direct offering for aggregate gross proceeds of approximately $2.0 million (the "Offering").The Series A warrants will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares issuable upon exercise of the warrants (the "Stockholder Approval Date") and will expire five years from the Stockholder Approval Date. The Series B warrants will be exercisable beginning on the Stockholder Approval Date and will expire 18 months from the Stockholder Approval Date. The purchase price for one share of common stock (or pre-funded warrants in lieu thereof) and accompanying two warrants is $1.83. Approximately $2.0 million will be funded in full upon the closing of the Offering, and up to an additional $4.0 million may be funded upon full cash exercise of the warrants. No assurance can be given that any of the warrants will be exercised.

Text size:

Inspire intends to use the net proceeds from the Offering for working capital, general corporate purposes, strategic investments, and any additional potential future acquisitions.

D. Boral Capital acted as exclusive placement agent for the offering.

The Crone Law Group, PC acted as legal counsel to Inspire Veterinary Partners, Inc. and Sichenzia Ross Ference Carmel LLP acted as legal counsel to D. Boral Capital for the Offering.

The common stock (or pre-funded warrants in lieu thereof), warrants and the shares of common stock underlying the warrants described above were offered by the Company pursuant to a "shelf" registration statement on Form S-3 (File No. 333-282355) that was declared effective by the Securities and Exchange Commission (the "SEC") on October 11, 2024. The Offering of the shares of common stock (or pre-funded warrants in lieu thereof), warrants and the shares of common stock underlying the warrants in the registered direct offering was made only by means of a prospectus, including a prospectus supplement, forming a part of the effective registration statement. A final prospectus supplement and accompanying prospectus relating to the registered direct offering has been filed with the SEC. Electronic copies of the final prospectus supplement and accompanying prospectus may be obtained on the SEC's website at http://www.sec.gov and may also be obtained by contacting D. Boral Capital at 590 Madison Ave 39th Floor, New York, New York 10022, by phone at (212) 970-5150 or e-mail at [email protected].

This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Inspire Veterinary Partners, Inc.

Inspire Veterinary Partners is an owner/operator of veterinary hospitals in the US. As the Company expands, it expects to acquire additional veterinary hospitals, including general practice, mixed animal facilities, and critical and emergency care.

For more information, please visit: www.inspirevet.com.

Connect with Inspire Veterinary Partners, Inc.

Facebook

https://www.facebook.com/InspireVeterinaryPartners/

LinkedIn

https://www.linkedin.com/company/inspire-veterinary-partners/

Forward-Looking Statements

This press release contains forward-looking statements regarding the Company's current expectations. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Factors that could cause actual results to differ include, but are not limited to, statements by the Company relating to the intended use of proceeds from the offering, receipt of Stockholder Approval, exercise of the Series A warrants and Series B warrants as well as risks and uncertainties related to the satisfaction of customary closing conditions related to anticipated acquisitions, or factors that result in changes to the Company's anticipated results of operations related to acquisitions. These and other risks and uncertainties are described more fully in the section captioned "Risk Factors" in the Company's public filings made with the Securities and Exchange Commission, including its Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Forward-looking statements contained in this announcement are made as of this date, and the Company undertakes no duty to update such information except as required under applicable law.

Investor Contact

TraDigital IR
Kevin McGrath
+1-646-418-7002
[email protected]

General Inquires

Morgan Wood
[email protected]

SOURCE: Inspire Veterinary Partners, Inc.



View the original press release on ACCESS Newswire

G.Dominguez--TFWP